Single tertiary center experience from Turkey regarding the experience for cardiac implantable electrical devices


Ozdemir E., Altin M. P., Emren S. V., Nazli C., Tokac M.

Kuwait Medical Journal, cilt.54, sa.2, ss.188-195, 2022 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 54 Sayı: 2
  • Basım Tarihi: 2022
  • Dergi Adı: Kuwait Medical Journal
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE
  • Sayfa Sayıları: ss.188-195
  • Anahtar Kelimeler: cardiac implantable electrical devices, complication, implantable cardioverter defibrillator, pacemaker
  • Atatürk Üniversitesi Adresli: Hayır

Özet

© 2022, Kuwait Medical Association. All rights reserved.Objective: To present our experience of cardiac implantable electrical devices (CIED) implantation and complications in a tertiary referral centre and to compare these data with literature Design: Retrospective observational study Setting: Izmir Katip Çelebi Universty, Ataturk Research and Education Hospital, Turkey Subjects: One thousand two hundred and nine de-novo CIED patients and 50 patients who underwent revision and battery exchange procedures Intervention: Hospital records were scanned. Main outcome measures: Compared to most other studies in literature, the population of this study was younger. The complication rate of cardiac resynchronization therapy (CRT) implantation was low, but the actual cause of six of the 10 mortalities could not be determined. Results: 38.6% (n=486) of patients had a cardiac pacemaker (CPM), 53.6% (n=675) an implantable cardioverter-defibrillators (ICD), and 7.8% (n=98) had CRT-D. The mean age of patients was 63.9±14.8 years and 66.8% (n=842) were male. The main indication for ICDs was primary prevention in 715 (56.8%) patients. The main indications for CPM implantation were as follows: 234 (18.6%) complete atrioventricular block and 83 (6.6%) sick sinus syndrome. The mean left ventricular ejection fraction value was 39.5%±16.5 before CIED implantation and 40.1%±%16.1 after CIED implantation. Device infection was determined at 2.1% (n=27); pocket infection at 1.7% (21), pneumothorax at 0.6% (n=7) and tamponade at 30.3% (n=3). The rate of pocket hematoma was 3.4% (n=42). Mortality occurred in 10 patients. Subclavian thrombus developed in three patients, shock in 773 and lead dysfunction in 70 patients. Conclusion: In contrast to general knowledge, no gender difference was determined in terms of complication rates, which were also lower than literature rates, despite operation complexity. Therefore, these data present different knowledge from the data available in literature.